NUWE
Nuwellis, Inc.
Key Financials
Revenue
$8.3M
↓ 5.4%
Operating Income
$-11106000
↓ 1.1%
EPS (Diluted)
$-25.39
↓ 201.9%
Net Income
$-17521000
↓ 56.9%
Gross Profit
$5.1M
↓ 9.7%
Total Assets
$6.1M
↓ 38.0%
Shareholders' Equity
$2.6M
↓ 59.8%
Total Liabilities
$3.5M
↑ 4.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 4/6/2026 | View on SEC |
| ARS | 4/2/2026 | View on SEC |
| DEF 14A | 4/2/2026 | View on SEC |
| 8-K/A | 4/1/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 10-K | 3/11/2026 | View on SEC |
| 8-K | 3/10/2026 | View on SEC |
| 3 | 3/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NUWE |
| Company Name | Nuwellis, Inc. |
| CIK | 1506492 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 952-345-4200 |